178 related articles for article (PubMed ID: 29671226)
1. LncRNA LINC00152 promoted glioblastoma progression through targeting the miR-107 expression.
Liu X; Yidayitula Y; Zhao H; Luo Y; Ma X; Xu M
Environ Sci Pollut Res Int; 2018 Jun; 25(18):17674-17681. PubMed ID: 29671226
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA LINC00152 promotes gallbladder cancer metastasis and epithelial-mesenchymal transition by regulating HIF-1α via miR-138.
Cai Q; Wang Z; Wang S; Weng M; Zhou D; Li C; Wang J; Chen E; Quan Z
Open Biol; 2017 Jan; 7(1):. PubMed ID: 28077595
[TBL] [Abstract][Full Text] [Related]
3. LINC00152 acts as a potential marker in gliomas and promotes tumor proliferation and invasion through the LINC00152/miR-107/RAB10 axis.
Peng G; Su J; Xiao S; Liu Q
J Neurooncol; 2021 Sep; 154(3):285-299. PubMed ID: 34478013
[TBL] [Abstract][Full Text] [Related]
4. Linc00152 promotes cancer progression in hepatitis B virus-associated hepatocellular carcinoma.
Deng X; Zhao XF; Liang XQ; Chen R; Pan YF; Liang J
Biomed Pharmacother; 2017 Jun; 90():100-108. PubMed ID: 28343069
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA CASC2 targeting miR-18a suppresses glioblastoma cell growth, metastasis and EMT
Wang J; Qin C; Zhong C; Wen Y; Ke S; Liao BO
J Biosci; 2020; 45():. PubMed ID: 32975234
[TBL] [Abstract][Full Text] [Related]
6. Down-regulation of lncRNA Linc00152 suppressed cell viability, invasion, migration, and epithelial to mesenchymal transition, and reversed chemo-resistance in breast cancer cells.
Hu XL; Wang J; He W; Zhao P; Wu WQ
Eur Rev Med Pharmacol Sci; 2018 May; 22(10):3074-3084. PubMed ID: 29863253
[TBL] [Abstract][Full Text] [Related]
7. Long Intergenic Noncoding RNA 00152 Promotes Glioma Cell Proliferation and Invasion by Interacting with MiR-16.
Chen X; Li D; Gao Y; Tang W; Iw L; Cao Y; Hao B
Cell Physiol Biochem; 2018; 46(3):1055-1064. PubMed ID: 29669323
[TBL] [Abstract][Full Text] [Related]
8. Long noncoding RNA LINC00152 promotes cell proliferation through competitively binding endogenous miR-125b with MCL-1 by regulating mitochondrial apoptosis pathways in ovarian cancer.
Chen P; Fang X; Xia B; Zhao Y; Li Q; Wu X
Cancer Med; 2018 Sep; 7(9):4530-4541. PubMed ID: 30030896
[TBL] [Abstract][Full Text] [Related]
9.
Reon BJ; Takao Real Karia B; Kiran M; Dutta A
Mol Cancer Res; 2018 Oct; 16(10):1470-1482. PubMed ID: 29991527
[TBL] [Abstract][Full Text] [Related]
10. Blocking LINC00152 suppresses glioblastoma malignancy by impairing mesenchymal phenotype through the miR-612/AKT2/NF-κB pathway.
Cai J; Zhang J; Wu P; Yang W; Ye Q; Chen Q; Jiang C
J Neurooncol; 2018 Nov; 140(2):225-236. PubMed ID: 30043319
[TBL] [Abstract][Full Text] [Related]
11. Long non-coding RNA NNT-AS1 promotes cholangiocarcinoma cells proliferation and epithelial-to-mesenchymal transition through down-regulating miR-203.
Gu Y; Zhu Z; Pei H; Xu D; Jiang Y; Zhang L; Xiao L
Aging (Albany NY); 2020 Feb; 12(3):2333-2346. PubMed ID: 32019904
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-663 inhibits the proliferation, migration and invasion of glioblastoma cells via targeting TGF-β1.
Li Q; Cheng Q; Chen Z; Peng R; Chen R; Ma Z; Wan X; Liu J; Meng M; Peng Z; Jiang B
Oncol Rep; 2016 Feb; 35(2):1125-34. PubMed ID: 26717894
[TBL] [Abstract][Full Text] [Related]
13. Mir-370-3p Impairs Glioblastoma Stem-Like Cell Malignancy Regulating a Complex Interplay between HMGA2/HIF1A and the Oncogenic Long Non-Coding RNA (lncRNA) NEAT1.
Lulli V; Buccarelli M; Ilari R; Castellani G; De Dominicis C; Di Giamberardino A; D Alessandris QG; Giannetti S; Martini M; Stumpo V; Boe A; De Luca G; Biffoni M; Marziali G; Pallini R; Ricci-Vitiani L
Int J Mol Sci; 2020 May; 21(10):. PubMed ID: 32443824
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA LINC00152/miR-613/CD164 axis regulates cell proliferation, apoptosis, migration and invasion in glioma via PI3K/AKT pathway.
Zhang L; Wang Y; Su H
Neoplasma; 2020 Jul; 67(4):762-772. PubMed ID: 32726126
[TBL] [Abstract][Full Text] [Related]
15. Linc00152 promotes malignant progression of glioma stem cells by regulating miR-103a-3p/FEZF1/CDC25A pathway.
Yu M; Xue Y; Zheng J; Liu X; Yu H; Liu L; Li Z; Liu Y
Mol Cancer; 2017 Jun; 16(1):110. PubMed ID: 28651608
[TBL] [Abstract][Full Text] [Related]
16. The noncoding RNA LINC00152 conveys contradicting effects in different glioblastoma cells.
Binder S; Zipfel I; Müller C; Wiedemann K; Schimmelpfennig C; Pfeifer G; Reiche K; Hauschildt S; Lehmann J; Köhl U; Horn F; Friedrich M
Sci Rep; 2021 Sep; 11(1):18499. PubMed ID: 34531451
[TBL] [Abstract][Full Text] [Related]
17. Long intergenic non‑protein coding RNA 152 promotes multiple myeloma progression by negatively regulating microRNA‑497.
Yu T; Xu Z; Zhang X; Men L; Nie H
Oncol Rep; 2018 Dec; 40(6):3763-3771. PubMed ID: 30272368
[TBL] [Abstract][Full Text] [Related]
18. LINC00152 down-regulated
Huang Y; Luo H; Li F; Yang Y; Ou G; Ye X; Li N
Biosci Rep; 2018 Jun; 38(3):. PubMed ID: 29339419
[TBL] [Abstract][Full Text] [Related]
19. Knockdown of linc00152 inhibits the progression of gastric cancer by regulating microRNA-193b-3p/ETS1 axis.
Wang H; Chen W; Yang P; Zhou J; Wang K; Tao Q
Cancer Biol Ther; 2019; 20(4):461-473. PubMed ID: 30404587
[TBL] [Abstract][Full Text] [Related]
20. The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression.
Wu W; Yu T; Wu Y; Tian W; Zhang J; Wang Y
J Exp Clin Cancer Res; 2019 Mar; 38(1):133. PubMed ID: 30898167
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
